Schizophrenia
📧 Sign up to get email alerts when something new happens for Schizophrenia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-05-22Clinical Trial Update: Effectiveness of the Screen, Test, Immunize, Reduce Risk, and Refer (STIRR) Intervention for People With Both a Mental and Substance Abuse Disorder [Phase 2]
Phase 2 clinical trial evaluating the STIRR intervention for people with co-occurring mental illness and substance use disorders; results we…
-
CLINICAL_TRIALS trial_result · 2013-05-22Clinical Trial Update: Lifestyle Intervention for Weight Gain Management for Patients With Schizophrenia [NA]
A completed clinical trial evaluated a lifestyle intervention to manage weight gain in patients with schizophrenia and obesity, with results…
-
CLINICAL_TRIALS trial_result · 2013-05-06Clinical Trial Update: Efficacy and Tolerability of Switching to Ziprasidone From Other Antipsychotics [Phase 4]
Phase 4 trial assessing efficacy and tolerability of switching to ziprasidone from other antipsychotics in schizophrenia and schizoaffective…
-
CLINICAL_TRIALS trial_result · 2013-05-03Clinical Trial Update: An Open Trial of Allopurinol in Patients With Poorly Responsive Schizophrenia [NA]
Open trial evaluating allopurinol in patients with poorly responsive schizophrenia; completed with results posted in 2013.
-
CLINICAL_TRIALS trial_result · 2013-04-18Clinical Trial Update: A Pharmacokinetic and Safety Study of Paliperidone Palmitate (JNS010) in Participants With Schizophrenia [Phase 2]
This Phase 2 study evaluates the pharmacokinetics and safety of paliperidone palmitate in participants with schizophrenia.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-04-09Clinical Trial Update: Melatonin for Prevention of Metabolic Side Effects of Olanzapine [Phase 2]
A Phase 2 clinical trial testing whether melatonin can prevent metabolic side effects from olanzapine in schizophrenia has completed.
-
CLINICAL_TRIALS trial_result · 2013-04-09Clinical Trial Update: Treating Thought Problems in Patients With Schizophrenia [NA]
The document provides a status update on a completed clinical trial studying treatments for thought problems in patients with schizophrenia.
-
CLINICAL_TRIALS trial_result · 2013-04-08Clinical Trial Update: Study Comparing Patients Taking Olanzapine and Patients Taking Aripiprazole on Learning of Vocational Skills [NA]
A completed clinical trial comparing olanzapine and aripiprazole examines the impact on learning vocational skills in individuals with schiz…
-
CLINICAL_TRIALS trial_result · 2013-04-04Clinical Trial Update: Decreasing the Use of Unmodified Electroconvulsive Therapy (ECT) in an Indian Hospital [NA]
Completed clinical trial assessing strategies to reduce the use of unmodified electroconvulsive therapy in an Indian hospital, across major …
-
CLINICAL_TRIALS trial_result · 2013-04-02Clinical Trial Update: Study With Information Technology (IT) - Aided Preventive Program in Schizophrenia [NA]
A completed clinical trial conducted by Prague Psychiatric Center evaluated an information-technology–aided preventive program for schizophr…
-
CLINICAL_TRIALS trial_result · 2013-03-29Clinical Trial Update: Pharmacological Approach to Improve the Outcome of Social Cognition Training [Phase 1]
Phase 1 clinical trial evaluating a pharmacological approach to improve social cognition training in schizophrenia has completed.
-
CLINICAL_TRIALS trial_result · 2013-03-29Clinical Trial Update: Social Cognition and Interaction Training for Improving Social Functioning in People With Schizophrenia [Phase 1]
Phase 1 clinical trial update reporting the completion of a study evaluating Social Cognition and Interaction Training (SCIT) to improve soc…
-
CLINICAL_TRIALS trial_result · 2013-03-29Clinical Trial Update: Graduated Recovery Intervention Program for Enhancing Treatment for First-Episode Psychosis [NA]
Completed clinical trial update from the University of North Carolina at Chapel Hill about a Graduated Recovery Intervention Program to enha…
-
CLINICAL_TRIALS trial_result · 2013-03-27Clinical Trial Update: The Use of Metformin in the Treatment of Antipsychotic-Induced Weight Gain in Schizophrenia (The METS Study) [Phase 4]
Phase 4 METS study evaluating metformin for antipsychotic-induced weight gain in schizophrenia; results posted in 2013.
-
CLINICAL_TRIALS trial_result · 2013-03-26Clinical Trial Update: Efficacy and Safety Study of Clozapine Augmented by Atomoxetine Versus Clozapine Augmented by Placebo in Patients With Chronic Resistant Schizophrenia [Phase 3]
Phase 3 trial evaluating clozapine augmented with atomoxetine versus clozapine augmented with placebo in chronic resistant schizophrenia; th…
-
CLINICAL_TRIALS trial_result · 2013-03-25Clinical Trial Update: A Pilot Study of the Use of Risperidone Long Acting Injectable in the Treatment of Patients With Recent Onset Psychosis [Phase 3]
A Phase 3 pilot study evaluated risperidone long-acting injectable for patients with recent-onset psychosis associated with schizophrenia. T…
-
CLINICAL_TRIALS trial_result · 2013-03-22Clinical Trial Update: Dental Status of Patients With Severe Mental Illness
Completed clinical trial evaluating dental health status in patients with severe mental illness, including schizophrenia, bipolar disorder, …
-
CLINICAL_TRIALS trial_result · 2013-03-15Clinical Trial Update: Tolerability, Safety and Efficacy of Flexibly Dosed Paliperidone ER in Patients With Schizophrenia [Phase 4]
Phase 4 trial evaluating tolerability, safety and efficacy of flexibly dosed Paliperidone ER in schizophrenia. The results were posted in 20…
-
CLINICAL_TRIALS trial_result · 2013-03-15Clinical Trial Update: Switching to Iloperidone From Other Antipsychotics in Schizophrenia [Phase 4]
Phase 4 trial evaluating switching schizophrenia patients from other antipsychotics to iloperidone; results were posted in 2013.
-
CLINICAL_TRIALS trial_result · 2013-03-14Clinical Trial Update: Appetite Increase in Schizophrenia Patients Treated With Atypical Antipsychotics [Phase 4]
Phase 4 trial update reports appetite increases observed in schizophrenia patients treated with atypical antipsychotics.
-
CLINICAL_TRIALS trial_result · 2013-03-14Clinical Trial Update: Metabolic Effects of Melatonin in Patients Treated With Second Generation Antipsychotics [Phase 4]
Phase 4 clinical trial evaluating whether melatonin mitigates metabolic adverse effects in patients treated with second generation antipsych…
-
CLINICAL_TRIALS trial_result · 2013-03-06Clinical Trial Update: Rosiglitazone for Clozapine Induced Glucose Metabolism Impairment [Phase 4]
Phase 4 trial evaluating rosiglitazone added to clozapine in schizophrenia patients with glucose metabolism impairment; the study was comple…
-
CLINICAL_TRIALS trial_result · 2013-03-05Clinical Trial Update: Safety and Efficacy Study of Paliperidone Extended Release (ER) Among Thai Schizophrenia Participants [Phase 4]
Phase 4 safety and efficacy study of paliperidone extended-release in Thai participants with schizophrenia; results posted in 2013.
-
CLINICAL_TRIALS trial_result · 2013-03-01Clinical Trial Update: Huperzine for Cognitive and Functional Impairment in Schizophrenia [Phase 2]
A Phase 2 clinical trial evaluating huperzine for cognitive and functional impairment in schizophrenia has completed. The study was sponsore…
-
CLINICAL_TRIALS trial_result · 2013-02-28Clinical Trial Update: Add-On Therapy to Risperidonein Schizophrenia [Phase 2, Phase 3]
Reports on a completed Phase 2/Phase 3 trial evaluating an add-on therapy to risperidone for schizophrenia.